Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt flag Egypt · Delayed Price · Currency is EGP
85.89
-0.29 (-0.34%)
At close: Apr 23, 2026

EGX:PHAR Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
14,49413,0796,8295,4303,6214,155
Market Cap Growth
96.84%91.51%25.78%49.96%-12.86%-3.57%
Enterprise Value
22,14721,42614,5789,6305,3885,509
Last Close Price
85.8977.5043.1732.6823.7125.05
PE Ratio
9.669.076.236.605.638.52
Forward PE
9.937.037.035.925.776.23
PS Ratio
1.541.390.901.040.921.22
PB Ratio
2.222.001.471.271.121.40
P/TBV Ratio
2.342.111.481.281.121.40
P/OCF Ratio
13.2511.96-58.71-10.83
PEG Ratio
-1.021.021.021.021.02
EV/Sales Ratio
2.352.271.921.841.361.62
EV/EBITDA Ratio
7.508.739.127.337.106.35
EV/EBIT Ratio
7.819.159.707.958.147.09
Debt / Equity Ratio
1.351.351.981.150.880.59
Debt / EBITDA Ratio
3.583.585.763.743.762.03
Net Debt / Equity Ratio
1.131.131.701.000.730.49
Net Debt / EBITDA Ratio
3.003.004.963.233.131.67
Net Debt / FCF Ratio
-28.20-28.20-1.92-1.93-2.77-27.25
Asset Turnover
0.560.560.600.630.660.66
Inventory Turnover
1.421.421.461.361.211.08
Quick Ratio
0.660.660.450.650.540.67
Current Ratio
1.161.161.381.941.722.13
Return on Equity (ROE)
26.06%26.06%24.60%21.95%20.71%16.78%
Return on Assets (ROA)
8.70%8.70%7.41%9.04%6.89%9.46%
Return on Invested Capital (ROIC)
13.55%14.55%10.36%13.21%10.69%14.11%
Return on Capital Employed (ROCE)
22.30%22.30%15.80%16.90%16.10%21.70%
Earnings Yield
9.95%11.02%16.04%15.14%17.76%11.74%
FCF Yield
-1.80%-2.00%-60.34%-40.48%-23.75%-1.28%
Dividend Yield
1.75%-3.48%3.06%4.22%5.99%
Payout Ratio
42.41%42.41%39.61%37.67%61.14%78.64%
Buyback Yield / Dilution
-8.93%-9.01%--50.00%--1.64%
Total Shareholder Return
-7.18%-9.01%3.48%-46.94%4.22%4.35%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.